Cargando…

Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study

OBJECTIVE: Data on the risk of ischemic heart disease (IHD) in patients with chronic hepatitis B virus (CHB) are conflicting. Our objective was to address the rate of IHD in patients with CHB compared with individuals without CHB (control-persons) from the general population. STUDY DESIGN AND SETTIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Frederik Faergemann, Bollerup, Signe, Engsig, Frederik, Krarup, Henrik, Mygind, Lone Hagens, Hansen, Jesper Bach, Madsen, Lone Galmstrup, Thielsen, Peter, Balslev, Ulla, Nielsen, Lars Nørregaard, Barfod, Toke S, Clausen, Mette Rye, Hobolth, Lise, Laursen, Alex Lund, Tarp, Britta, Roege, Birgit T, Gerstoft, Jan, Christensen, Peer Brehm, Weis, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307867/
https://www.ncbi.nlm.nih.gov/pubmed/35879942
http://dx.doi.org/10.2147/CLEP.S361910
_version_ 1784752856532779008
author Lau, Frederik Faergemann
Bollerup, Signe
Engsig, Frederik
Krarup, Henrik
Mygind, Lone Hagens
Hansen, Jesper Bach
Madsen, Lone Galmstrup
Thielsen, Peter
Balslev, Ulla
Nielsen, Lars Nørregaard
Barfod, Toke S
Clausen, Mette Rye
Hobolth, Lise
Laursen, Alex Lund
Tarp, Britta
Roege, Birgit T
Gerstoft, Jan
Christensen, Peer Brehm
Weis, Nina
author_facet Lau, Frederik Faergemann
Bollerup, Signe
Engsig, Frederik
Krarup, Henrik
Mygind, Lone Hagens
Hansen, Jesper Bach
Madsen, Lone Galmstrup
Thielsen, Peter
Balslev, Ulla
Nielsen, Lars Nørregaard
Barfod, Toke S
Clausen, Mette Rye
Hobolth, Lise
Laursen, Alex Lund
Tarp, Britta
Roege, Birgit T
Gerstoft, Jan
Christensen, Peer Brehm
Weis, Nina
author_sort Lau, Frederik Faergemann
collection PubMed
description OBJECTIVE: Data on the risk of ischemic heart disease (IHD) in patients with chronic hepatitis B virus (CHB) are conflicting. Our objective was to address the rate of IHD in patients with CHB compared with individuals without CHB (control-persons) from the general population. STUDY DESIGN AND SETTING: We conducted a cohort study of prospectively obtained data from Danish nationwide registries. We produced cumulative incidence curves and calculated the unadjusted incidence rate ratio (IRR) of IHD in persons with and without CHB. The adjusted association between having CHB and developing IHD was examined using a cause-specific Cox regression model. RESULTS: In total, 6472 persons with CHB and 62,251 age- and sex-matched individuals from the general population were followed for 48,840 and 567,456 person-years, respectively, during which 103 (1,59%) with CHB and 1058 (1,70%) control-persons developed IHD. The crude IRR was 1.13 (95% CI: 0.91–1.39). CHB did not have a statistically significant effect on the rate of IHD after adjusting for several confounding factors (adjusted hazard ratio: 0.96, 95% CI: 0.76–1.21). CONCLUSION: In this nationwide cohort study, we did not find any difference between rate of IHD in persons with CHB in comparison with the general population.
format Online
Article
Text
id pubmed-9307867
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93078672022-07-24 Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study Lau, Frederik Faergemann Bollerup, Signe Engsig, Frederik Krarup, Henrik Mygind, Lone Hagens Hansen, Jesper Bach Madsen, Lone Galmstrup Thielsen, Peter Balslev, Ulla Nielsen, Lars Nørregaard Barfod, Toke S Clausen, Mette Rye Hobolth, Lise Laursen, Alex Lund Tarp, Britta Roege, Birgit T Gerstoft, Jan Christensen, Peer Brehm Weis, Nina Clin Epidemiol Original Research OBJECTIVE: Data on the risk of ischemic heart disease (IHD) in patients with chronic hepatitis B virus (CHB) are conflicting. Our objective was to address the rate of IHD in patients with CHB compared with individuals without CHB (control-persons) from the general population. STUDY DESIGN AND SETTING: We conducted a cohort study of prospectively obtained data from Danish nationwide registries. We produced cumulative incidence curves and calculated the unadjusted incidence rate ratio (IRR) of IHD in persons with and without CHB. The adjusted association between having CHB and developing IHD was examined using a cause-specific Cox regression model. RESULTS: In total, 6472 persons with CHB and 62,251 age- and sex-matched individuals from the general population were followed for 48,840 and 567,456 person-years, respectively, during which 103 (1,59%) with CHB and 1058 (1,70%) control-persons developed IHD. The crude IRR was 1.13 (95% CI: 0.91–1.39). CHB did not have a statistically significant effect on the rate of IHD after adjusting for several confounding factors (adjusted hazard ratio: 0.96, 95% CI: 0.76–1.21). CONCLUSION: In this nationwide cohort study, we did not find any difference between rate of IHD in persons with CHB in comparison with the general population. Dove 2022-07-18 /pmc/articles/PMC9307867/ /pubmed/35879942 http://dx.doi.org/10.2147/CLEP.S361910 Text en © 2022 Lau et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lau, Frederik Faergemann
Bollerup, Signe
Engsig, Frederik
Krarup, Henrik
Mygind, Lone Hagens
Hansen, Jesper Bach
Madsen, Lone Galmstrup
Thielsen, Peter
Balslev, Ulla
Nielsen, Lars Nørregaard
Barfod, Toke S
Clausen, Mette Rye
Hobolth, Lise
Laursen, Alex Lund
Tarp, Britta
Roege, Birgit T
Gerstoft, Jan
Christensen, Peer Brehm
Weis, Nina
Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
title Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
title_full Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
title_fullStr Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
title_full_unstemmed Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
title_short Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study
title_sort ischemic heart disease in chronic hepatitis b: a danish nationwide cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307867/
https://www.ncbi.nlm.nih.gov/pubmed/35879942
http://dx.doi.org/10.2147/CLEP.S361910
work_keys_str_mv AT laufrederikfaergemann ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT bollerupsigne ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT engsigfrederik ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT kraruphenrik ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT mygindlonehagens ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT hansenjesperbach ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT madsenlonegalmstrup ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT thielsenpeter ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT balslevulla ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT nielsenlarsnørregaard ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT barfodtokes ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT clausenmetterye ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT hobolthlise ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT laursenalexlund ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT tarpbritta ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT roegebirgitt ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT gerstoftjan ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT christensenpeerbrehm ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy
AT weisnina ischemicheartdiseaseinchronichepatitisbadanishnationwidecohortstudy